MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cncr.70151

Медицинская библиотека · Cancer · 2025

Integrating surgery and targeted therapies in the management of recurrent/metastatic gastrointestinal stromal tumors.

Yan Miao, Zhang Xinhua, Li Mingzhe, Qian Haoran, He Yulong

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Targeted therapy with tyrosine kinase inhibitors (TKIs) has revolutionized the treatment of unresectable advanced gastrointestinal stromal tumors (GISTs), significantly prolonging the survival and improving the quality of life of affected patients worldwide. However, resistance to TKIs inevitably occurs. Surgery following TKI therapy has been investigated for its clinical benefits in patients with advanced GISTs. Recent advancements have enhanced our understanding of using TKIs to create opportunities for and facilitate subsequent surgical interventions. These interventions appear feasible for highly selected cases and demonstrate survival benefits. Current evidence primarily comes from combining first-line treatment with imatinib and surgery, with limited clinical studies on second- and later-line TKIs. When formulating optimal treatment strategies, key factors such as surgical timing, factors influencing surgical benefit (including treatment response, disease extent at the time of surgery, and completeness of surgery), surgical morbidity, and TKI selection should be carefully assessed. Multidisciplinary care involving targeted therapy with suitable TKIs and appropriate surgical modalities may extend the duration of TKI treatment and improve associated clinical outcomes. Therefore, further studies, particularly randomized trials, on a global scale, are warranted. This commentary review offers insights for treatment decision-making in clinical practice, aiming to optimize patient-centered care for individuals with advanced GISTs and ultimately enhance survival benefits and quality of life for these patients.

Для цитирования: Yan Miao, Zhang Xinhua, Li Mingzhe, Qian Haoran, He Yulong. Integrating surgery and targeted therapies in the management of recurrent/metastatic gastrointestinal stromal tumors.. Cancer. 2025. DOI: 10.1002/cncr.70151.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.